Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 753 Jan 1 – Oct 25, 2026
- Disclosed funding
- $25.9B 612 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
 IMU BiosciencesCompany profile Profiles human immune systems using multi-omic analysis and machine learning for disease research. Profiles human immune systems using multi-omic analysis and machine learning for disease research. | $53M | Series A | Healthtech, Biotech | United Kingdom | Investors | |
| TB Develops novel therapeutics for glaucoma and retinal diseases | $17M | Series A | Healthtech, Biotech | United States | Investors | |
| C ContralineCompany profile Develops hormonal and non-hormonal male contraceptives for men and couples globally Develops hormonal and non-hormonal male contraceptives for men and couples globally | $92.5M | Series B | Healthtech, Biotech | United States | Investors | |
| SM Subtle MedicalCompany profile Develops AI-powered medical imaging software to improve workflow efficiency and image quality Develops AI-powered medical imaging software to improve workflow efficiency and image quality | $33M | Growth | Healthtech | United States | Investors | |
| N NovelliaCompany profile Platform that unifies patient health records for individuals and supplies anonymized data to pharma researchers Platform that unifies patient health records for individuals and supplies anonymized data to pharma researchers | $18M | Series A | Healthtech | United States | Investors | |
 NewLimitCompany profile NewLimit develops epigenetic reprogramming medicines designed to restore function in aging cells and treat age-related disease. NewLimit develops epigenetic reprogramming medicines designed to restore function in aging cells and treat age-related disease. | $435M | Series CSeries C+ | Healthtech, Biotech | United States | Investors | |
| VA Veritas Aortic SolutionsCompany profile Develops a non-surgical treatment for Aortic Root and Ascending Aortic Diseases Develops a non-surgical treatment for Aortic Root and Ascending Aortic Diseases | $12M | Seed | Healthtech | United States | Investors | |
| O OrebellaCompany profile Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail Makes alcohol-free bi-phase skin parfums using botanical and essential oil ingredients sold through Ulta Beauty and global specialty retail | Undisclosed | Series A | Healthtech, Consumer | United States | Investors | |
 Garner HealthCompany profile Helps patients choose healthcare providers using data and financial incentives. Helps patients choose healthcare providers using data and financial incentives. | $100M | Series ESeries C+ | Healthtech | United States | Investors | |
| KH Kubera HealthCompany profile Building the contract-to-payment system of record for American healthcare Building the contract-to-payment system of record for American healthcare | $6.5M | Seed | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.